Irbesartan Hennig

Irbesartan, the active ingredient in Irbesartan Hennig, is a Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It treats hypertension and diabetic nephropathy in adults.

GNH USA supplies Irbesartan Hennig as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Irbesartan belongs to the class of Angiotensin II receptor blockers and is used to manage conditions related to the renin‑angiotensin system. - Hypertension: lowers elevated blood pressure and reduces cardiovascular risk. - Diabetic nephropathy: slows the progression of kidney damage in patients with type 2 diabetes. - Proteinuria associated with diabetes: reduces urinary protein excretion, supporting renal protection.

Common Side Effects: - Dizziness: feeling light‑headed or unsteady. - Headache: mild to moderate head pain. - Fatigue: unusual tiredness or lack of energy. - Upper respiratory tract infection: cold‑like symptoms. - Diarrhea: loose stools. - Nasal congestion: blocked nose.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or throat. - Hyperkalemia: elevated blood potassium levels. - Acute kidney injury: sudden decline in renal function. - Hepatic injury: abnormal liver enzymes or hepatitis. - Severe hypotension: markedly low blood pressure. - Myocardial infarction: rare heart attack events.

Before initiating Irbesartan, consider the following safety measures. - Renal function: monitor serum creatinine and eGFR regularly. - Electrolytes: check potassium levels, especially if using potassium‑sparing agents. - Pregnancy: avoid use during the first trimester and discuss risks with a healthcare professional. - Concomitant potassium‑sparing diuretics: increased risk of hyperkalemia; use with caution. - Drug interactions: review all concurrent medications for potential interactions. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Irbesartan may interact with several medicines; awareness helps maintain safety. Major Interactions (Avoid): - ACE inhibitors: combined use raises the risk of angioedema. - Potassium supplements or potassium‑sparing diuretics: can cause dangerous hyperkalemia. - Aliskiren in diabetic patients: may increase renal adverse effects. Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive efficacy and affect renal function. - Lithium: Irbesartan can raise lithium concentrations, requiring level checks. - Thiazide diuretics: may enhance hypotensive effect; monitor blood pressure.